Key study characteristics were extracted, including first author, publication year, country, study design, GLP-1RA type, comparator group, outcome(s) of interest, follow-up duration, sample size, mean age, standard deviation (if available), and percentage of male participants
Conclusion This updated meta-analysis of randomised clinical trials demonstrated that the use of semaglutide in patients with or without T2DM was not associated with an increased risk of acute pancreatitis compared to placebo
These medications are available only as injections
They can determine whether dose adjustments, alternative medications, or additional interventions are needed to support your weight loss or blood sugar goals safely